SSA Proposes Changes to Cancer Listings

byron david, conway, scSSA has proposed changes to the current Malignant Neoplastic Diseases Listings of Impairments, sections 13.00, et seq., and 130.00, et seq.  78 Fed. Reg.76508 (December 17, 2013). Comments are due no later than February 18, 2014. Comments should refer to Docket No. SSA-2011-0098 and can be submitted either by Internet, fax, or regular mail. The notice of proposed rulemaking (NPRM) provides details for submission of comments.

These listings were last revised in 2009. An initial proposed revision is to change the name of this body system from “Malignant Neoplastic Diseases” to “Cancer.” The change would also be made to other places in the introductory text and listings.

Introductory text. As has been occurring with revisions to listings for other body systems, SSA proposes to reorder and expand the introductory text, section 13.00. Proposed changes include:

  • How cancer is evaluated when treated with multimodal antineoplastic therapy under certain listings. Adjudication could be deferred if the treating source plans multimodal therapy but has not yet initiated it.
  • Changes to definition of certain terms including “antineoplastic therapy,” “unresectable,” “persistent,” and “progressive.”
  • How some specific cancers are evaluated, e.g., chronic leukemia, primary breast cancer (including secondary lymphedema), central nervous system cancers, primary peritoneal cancer, recurrent prostate cancer, and malignant melanoma.
  • Evaluation of cancers treated with bone marrow or stem cell transplantation.

Specific cancers. Changes to specific cancers include the following:

  • Small-cell carcinoma. Currently, this is only appears in the lungs cancer listing. Since it can originate in places other than the lungs, a criterion would be added to the listings for the other places. Small-cell carcinomas are of listing-level severity regardless of where they occur in the body.
  • Soft Tissue Cancers of the Head and Neck (Proposed Listing 13.02)
  • Malignant Melanoma (Proposed Listing 13.29)
  • Lymphoma (Proposed Listing 13.05)
  • Breast (Proposed Listing 13.10)
  • Nervous System (Proposed Listing 13.13)
  • Pancreas (Proposed Listing 13.20)
  • Cancers of the Female Genital Tract (Proposed Listing 13.23)
  • Skin (Proposed Listing 13.03)

The NPRM also includes revisions to the listings for evaluating cancer in children, sections 113.00, et seq.


Posted on February 3, 2014, in Uncategorized and tagged , , , , , , , , . Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: